Exploring the link between ultra-processed foods and eosinophilic esophagitis
Official title: The Potential Role of Compounds Derived From Ultra-processed Foods in Pathogenesis of Eosinophilic Esophagitis
Run by Federico II University · NCT06093204 · Data updated 2026-11-12
This study is trying to see if eating ultra-processed foods is linked to eosinophilic esophagitis symptoms in kids and teens aged 3 to 18.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 3 Years to 65 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Federico II University Academic / other |
| Locations | 2 sites (Naples, Naples and 1 other locations) |
| Status | Recruiting |
| Started | April 12, 2023 |
| Main results expected | June 12, 2025 |
| Study ends | June 12, 2027 |
| Registry record updated | September 1, 2026 |
| Trial ID | NCT06093204 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children and adolescents aged 3 to 18 years with a confirmed diagnosis of eosinophilic esophagitis.
✕Probably not a fit
Patients with other chronic diseases or those outside the specified age range may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the potential role of compounds derived from ultra-processed foods in the development of eosinophilic esophagitis (EoE), a chronic inflammatory condition of the esophagus. It aims to evaluate dietary habits and their correlation with EoE symptoms in children and adolescents aged 3 to 18 years. Participants will include diagnosed EoE patients and age- and sex-matched healthy controls, with a focus on understanding how diet may influence the pathogenesis of this condition. The study will involve dietary evaluations to gather relevant data.
Why it matters
Potential benefit: If successful, this study could lead to dietary recommendations that help manage or prevent eosinophilic esophagitis in affected individuals.
How similar studies have gone: While the specific approach of linking ultra-processed foods to EoE is novel, similar dietary studies have shown promise in understanding other inflammatory conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * both sexes * age between 3-65 years * sure diagnosis of eosinophilic esophagitis * age- and sex-matched healthy controls * parents/tutor written informed consent. Exclusion Criteria: * lack of written informed consent; * non-Caucasian ethnicity * age at enrollment \< 3 or \>65 years * simultaneous presence of other chronic diseases: eosinophilic gastroenteritis, eosinophilic colitis, achalasia, GERD, hypereosinophilia syndrome, IBD, fungal or viral infections, connective tissue disorders, autoimmune diseases, vasculitis, bullous dermatosis with oesophageal involvement (pemphigus), drug hypersensitivity reactions, drug-induced oesophagitis, graft vs host disease, monogenic disorders (Marfan syndrome type 2, HIES, PTEN). * presence of tattoos, scars, moles or particular lesions on both forearms
Where it's running
-
Department of Traslational Medical Science - University of Naples Federico II
Naples, Naples, Italy Recruiting -
Department of Traslational Medical Science - University of Naples Federico II
Naples, Naples, Italy Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Probiotics for infant colic: does daily L. reuteri help crying time?
This study tests whether giving healthy infants with Rome IV–defined colic a daily probiotic (L. reuteri) reduces crying and fussing more quickly than a placebo.
-
Raw cornstarch and glucose readings in adults with glycogen storage disease type I
This study tests whether eating raw cornstarch with meals changes blood sugar after meals in adults with GSD I using continuous glucose monitoring.
-
Ranolazine to prevent coronary microvascular damage after STEMI in people with multivessel coronary disease
This trial will try ranolazine in adults who have a STEMI and remaining significant blockages to see if it protects the small blood vessels in the heart after emergency angioplasty.
-
Adherence, persistence, and real-life effectiveness of alirocumab 300 mg for people with high cholesterol in Italy
This project will test whether alirocumab 300 mg helps people with high cholesterol in Italy stick with their treatment and lower their cholesterol when used in routine care.
-
Cardiovascular risk and treatment patterns in adults with type 2 diabetes in Italy
This registry will collect information from adults with type 2 diabetes to see how their heart risk and medicines are managed in real-world Italian outpatient clinics.
-
Bempedoic acid adherence, persistence, and effect in adults in Italy
This project will see how well bempedoic acid works and how consistently adults with high cholesterol in Italy take it.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.